Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Astrocytoma (Phase 1)
Brain Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 1)
Carcinoma, Hepatocellular (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Colonic Neoplasms (Phase 1)
Colorectal Neoplasms (Early Phase 1)
Diffuse Intrinsic Pontine Glioma (Phase 1)
Digestive System Neoplasms (Phase 2)
Esophageal Neoplasms (Phase 1)
Fallopian Tube Neoplasms (Phase 1/Phase 2)
Gastrointestinal Diseases (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Glioblastoma (Phase 1/Phase 2)
Glioma (Phase 1)
Hamartoma (Phase 1/Phase 2)
Hodgkin Disease (Phase 1)
Lymphoma, Large B-Cell, Diffuse (Phase 1)
Melanoma (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Nerve Tissue (Phase 1)
Neuroblastoma (Phase 1)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 1/Phase 2)
Small Cell Lung Carcinoma (Phase 1)
Stomach Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue